Can Anaplasma IgM and IgG reactivity indicate active infection?

Anaplasmosis testing must distinguish immune evidence of exposure from direct evidence of current bacteremia. This is particularly consequential in an older adult, in whom the clinical context and timing of testing should strongly inform interpretation.

Serologic evidence

• IgM/IgG reactivity is compatible with immune exposure but does not establish active disease. A single acute IgG IFA titer—even ≥1:128—is supportive rather than confirmatory. IgM is not reliable evidence of recent infection because of nonspecific and false-positive reactivity.
• IgG may persist for 12–18 months and sometimes 3–4 years, so isolated positivity can represent remote infection rather than the cause of a current illness. Antibodies may also cross-react with Ehrlichia and related organisms.
• The strongest serologic evidence of recent infection is paired testing: acute serum in the first 2 weeks of illness and convalescent serum 2–10 weeks later, showing seroconversion or a ≥4-fold IgG titer rise.

Molecular testing and timing

• EDTA whole-blood PCR detects A. phagocytophilum in circulating leukocytes and is most useful early, particularly in the first week and before antimicrobial treatment. In one diagnostic cohort, sensitivity was approximately 74% and specificity 100%.
• Therefore, a negative PCR materially decreases support for active circulating infection, but cannot exclude it. Detectable bacteremia falls later in illness and can decline substantially within roughly 48 hours of doxycycline, increasing false-negative risk.

Bottom line

• The claim is well supported: antibody reactivity may indicate exposure but cannot, in a single pattern, confirm active anaplasmosis; a negative blood PCR lowers the probability of active bacteremia but remains conditional on illness timing, specimen collection, and doxycycline exposure.